BUHLMANN Diagnostics Corp released the fCAL® turbo calprotectin test, a non-invasive biomarker used for diagnosing IBD and differentiating IBD from IBS.
Public source
Publisher name
Public post
𝗧𝗲𝗰𝗵𝗻𝗶𝗰𝗮𝗹 𝗧𝘂𝗲𝘀𝗱𝗮𝘆 | 𝗗𝗶𝗱 𝗬𝗼𝘂 𝗞𝗻𝗼𝘄? 𝗡𝗼𝗻-𝗶𝗻𝘃𝗮𝘀𝗶𝘃𝗲 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝘁𝗲𝘀𝘁𝗶𝗻𝗴 𝗰𝗮𝗻 𝗽𝗿𝗼𝘃𝗶𝗱𝗲 𝘃𝗮𝗹𝘂𝗮𝗯𝗹𝗲 𝗶𝗻𝘀𝗶𝗴𝗵…
Company
BUHLMANN Diagnostics Corp
Built on Trust. Driven by Science. Focused on You.
- Industry
- Biotechnology Research
- Location
- Amherst, US
- Company size
- 2–10 employees
About BUHLMANN Diagnostics Corp
BÜHLMANN Diagnostics Corp (BDC) is a North American affiliate of BÜHLMANN Laboratories AG, a leading manufacturer of ELISA assay kits, RIA assay kits, lateral flow assays, flow cytometry assays, Turbidimetric assays, antibodies, and proteins worldwide. Located in a state-of-the-art facility in Southern New Hampshire, the BDC team collectively represents over 100 years of experience in serving both clinical and basic science research laboratories. BÜHLMANN offers the broadest calprotectin product range in the industry including BÜHLMANN fCAL® ELISA and quantitative Quantum Blue® Calprotectin rapid tests. All calprotectin products benefit from our patented easy, safe, and clean stool CALEX® sampling and extraction devices. Beyond our calprotectin brand, we also offer a selection of unique, high-quality assays for Cellular Allergy testing such as the BÜHLMANN Flow CAST® product group for Basophil Activation Testing and Neuroimmunology testing such as the BÜHLMANN GanglioCombi™ products; the only screening ELISAs for anti-Ganglioside testing. Other areas of BÜHLMANN’s focus include specialized niche products for Clinical Chemistry (ACE, GHB, etc) as well as the first- to-market Chronobiology melatonin line of assays. BÜHLMANN continues to renew and enlarge its product portfolio, with the aim to be a leader in selected fields of in vitro diagnostics and scientific research by combining innovation with traditional core values of quality products and superior service to our customers. BÜHLMANN is unique, independent, and reliable in every aspect of its business from the outstanding quality of its products, its excellent after-sales services, and its remarkable scientific innovations. Our North American affiliate will help us to continue to foster closer relationships with our customers and enhance our customer support interactions as well as meet your requirements for future BÜHLMANN products. Quality is not just a statement, but part of our daily mission.
See moreLatest activity
Latest activity from BUHLMANN Diagnostics Corp
2 signals
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
Vibrant Wellness
Vibrant Wellness launched Gut Zoomer New York, a comprehensive gut test for patients in New York.
Products & Services
MARAbio
MARAbio launched the MAR-Autism™ Test, a blood-based test for identifying specific maternal autoantibody patterns associated with Maternal Autoantibody-Related autism, designed for mothers with children diagnosed with autism or showing signs of autism.
Research & Knowledge
Immundiagnostik, Inc.
Immundiagnostik, Inc. published an article exploring calprotectin MRP8/14, its role in inflammatory diseases, sample types, and its value in longitudinal research.
Products & Services
ALPCO
ALPCO launched the KleeYa platform, combining fully automated random-access testing with a growing menu of flash chemiluminescence assays across gastroenterology, infectious disease, and therapeutic drug monitoring.
Products & Services
Seegene USA